DR. PRADEEP Y RAMULU MD
Prescription History 1003821521
Ophthalmology in Baltimore, MD
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. PRADEEP Y RAMULU MD, an active Ophthalmology specialist practicing in Baltimore, MD. Our medical registry currently tracks 20 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,452 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 464 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other MD PrescribersVs. MD Avg |
|---|---|---|---|
| Latanoprost | 464 | $20.29▼ below MD avg | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 464 Medicare prescriptions for Latanoprost, about 3.9 times the volume of the typical Maryland prescriber of this medication (119). Medicare paid an average of $20.29 per fill, versus $21.84 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 1,124.7 30-Day Fills standardized to 30-day supplies 33,506 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 246 | $31.00▼ below MD avg | ▲ More than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 246 Medicare prescriptions for Dorzolamide-Timolol, about 3 times the volume of the typical Maryland prescriber of this medication (81). Medicare paid an average of $31.00 per fill, versus $35.15 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 649.1 30-Day Fills standardized to 30-day supplies 19,471 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 149 | $67.25 | ▲ More than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 149 Medicare prescriptions for Brimonidine Tartrate, about 2.7 times the volume of the typical Maryland prescriber of this medication (55). Medicare paid an average of $67.25 per fill, versus $49.50 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 362.6 30-Day Fills standardized to 30-day supplies 10,761 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 144 | $13.53▼ below MD avg | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 144 Medicare prescriptions for Timolol Maleate, about 6.3 times the volume of the typical Maryland prescriber of this medication (23). Medicare paid an average of $13.53 per fill, versus $500.63 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 397.4 30-Day Fills standardized to 30-day supplies 11,859 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 82 | $63.12 | ≈ Typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 82 Medicare prescriptions for Prednisolone Acetate, about the same volume as the typical Maryland prescriber of this medication (88). Medicare paid an average of $63.12 per fill, versus $54.37 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 128.6 30-Day Fills standardized to 30-day supplies 3,567 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 47 | $31.86 | ≈ Typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 47 Medicare prescriptions for Dorzolamide Hcl, about the same volume as the typical Maryland prescriber of this medication (43). Medicare paid an average of $31.86 per fill, versus $31.70 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 123.9 30-Day Fills standardized to 30-day supplies 3,717 Days of Medication total across all patients in 2023 | |||
| RhopressaNetarsudil Mesylate | 46 | $801.92 | ≈ Typical |
About Rhopressa: Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness. In 2023, this provider wrote 46 Medicare prescriptions for Rhopressa, about the same volume as the typical Maryland prescriber of this medication (42). Medicare paid an average of $801.92 per fill, versus $555.26 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 105.3 30-Day Fills standardized to 30-day supplies 3,154 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 46 | $711.60 | ≈ Typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 46 Medicare prescriptions for Lumigan, about 79% of the volume of the typical Maryland prescriber of this medication (58). Medicare paid an average of $711.60 per fill, versus $563.04 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 116.4 30-Day Fills standardized to 30-day supplies 3,472 Days of Medication total across all patients in 2023 | |||
| Travoprost | 38 | $296.83▼ below MD avg | ≈ Typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 38 Medicare prescriptions for Travoprost, about 1.2 times the volume of the typical Maryland prescriber of this medication (32). Medicare paid an average of $296.83 per fill, versus $303.72 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 83.4 30-Day Fills standardized to 30-day supplies 2,502 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 32 | $213.51 | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 32 Medicare prescriptions for Dorzolamide-Timolol, about a third of the volume of the typical Maryland prescriber of this medication (81). Medicare paid an average of $213.51 per fill, versus $35.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 61 30-Day Fills standardized to 30-day supplies 1,815 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 27 | $664.43 | ▼ Less than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 27 Medicare prescriptions for Combigan, about 68% of the volume of the typical Maryland prescriber of this medication (40). Medicare paid an average of $664.43 per fill, versus $453.20 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 70.4 30-Day Fills standardized to 30-day supplies 2,100 Days of Medication total across all patients in 2023 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 22 | $296.42▼ below MD avg | ≈ Typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2023, this provider wrote 22 Medicare prescriptions for Simbrinza, about 88% of the volume of the typical Maryland prescriber of this medication (25). Medicare paid an average of $296.42 per fill, versus $309.23 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 43.9 30-Day Fills standardized to 30-day supplies 1,310 Days of Medication total across all patients in 2023 | |||
| Alphagan PBrimonidine Tartrate | 18 | $765.76 | ▼ Less than typical |
About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 18 Medicare prescriptions for Alphagan P, about half the volume of the typical Maryland prescriber of this medication (32). Medicare paid an average of $765.76 per fill, versus $456.78 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 43.8 30-Day Fills standardized to 30-day supplies 1,310 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 18 | $1,027.92▼ below MD avg | ▼ Less than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 18 Medicare prescriptions for Restasis, about half the volume of the typical Maryland prescriber of this medication (42). Medicare paid an average of $1,027.92 per fill, versus $1,301.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 32 30-Day Fills standardized to 30-day supplies 960 Days of Medication total across all patients in 2023 | |||
| Brinzolamide | 13 | $381.59▼ below MD avg | ▼ Less than typical |
About Brinzolamide: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 13 Medicare prescriptions for Brinzolamide, about half the volume of the typical Maryland prescriber of this medication (24). Medicare paid an average of $381.59 per fill, versus $383.78 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 41 30-Day Fills standardized to 30-day supplies 1,230 Days of Medication total across all patients in 2023 | |||
| VyzultaLatanoprostene Bunod | 13 | $598.93 | ▼ Less than typical |
About Vyzulta: Latanoprostene bunod is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by controlling the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 13 Medicare prescriptions for Vyzulta, about half the volume of the typical Maryland prescriber of this medication (26). Medicare paid an average of $598.93 per fill, versus $539.04 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26.7 30-Day Fills standardized to 30-day supplies 800 Days of Medication total across all patients in 2023 | |||
| TafluprostTafluprost/Pf | 12 | $212.12 | – No State Data |
About Tafluprost: Tafluprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 12 Medicare prescriptions for Tafluprost. Medicare paid an average of $212.12 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $212.12 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 615 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 12 | $354.08 | ▼ Less than typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 12 Medicare prescriptions for Brimonidine Tartrate-Timolol, about 63% of the volume of the typical Maryland prescriber of this medication (19). Medicare paid an average of $354.08 per fill, versus $345.12 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30.3 30-Day Fills standardized to 30-day supplies 910 Days of Medication total across all patients in 2023 | |||
| ZioptanTafluprost/Pf | 12 | $303.85▼ below MD avg | ▼ Less than typical |
About Zioptan: Tafluprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 12 Medicare prescriptions for Zioptan, about half the volume of the typical Maryland prescriber of this medication (25). Medicare paid an average of $303.85 per fill, versus $431.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 14 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2023 | |||
| Travatan ZTravoprost | 11 | $744.77 | ▼ Less than typical |
About Travatan Z: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 11 Medicare prescriptions for Travatan Z, about half the volume of the typical Maryland prescriber of this medication (20). Medicare paid an average of $744.77 per fill, versus $477.00 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26.2 30-Day Fills standardized to 30-day supplies 786 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. PRADEEP Y RAMULU MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Baltimore, MD practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among MD prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
